financetom
Business
financetom
/
Business
/
VW's trucks arm Traton sees 2024 margins in line after doubling annual profit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VW's trucks arm Traton sees 2024 margins in line after doubling annual profit
Mar 4, 2024 11:26 PM

(Reuters) - Volkswagen's trucks arm Traton on Tuesday forecast a 2024 return on sales in line with the previous year after its annual core earnings almost doubled thanks to record high post-pandemic pent-up demand for commercial vehicles.

The maker of MAN and Scania lorries sees the adjusted operating return on sales in the 8-9% range in 2024, in line with the 8.6% reported in the previous year.

The group's adjusted operating result jumped by 95% to 4 billion euros ($4.34 billion) in 2023, beating the consensus estimate compiled by Vara Research.

"With the market environment for trucks generally softening in some regions, we will remain extremely focused in 2024 and capitalize on our strengths," Chief Executive Christian Levin said.

The truck sector braces for a tougher 2024 with analysts flagging a downturn in demand in Europe and North America as it eases from historic highs reached last year thanks to the pent-up demand from the COVID pandemic.

The executive board said it would propose a dividend of 1.5 euros per share, which is more than twice higher than last year.

($1 = 0.9219 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $635,126, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $635,126, According to a Recent SEC Filing
Oct 3, 2025
05:19 PM EDT, 10/03/2025 (MT Newswires) -- Tolga Tanguler, Executive Vice President, Chief Commercial Officer, on October 01, 2025, sold 1,405 shares in Alnylam Pharmaceuticals ( ALNY ) for $635,126. Following the Form 4 filing with the SEC, Tanguler has control over a total of 27,438 common shares of the company, with 27,438 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178670/000173527625000115/xslF345X05/edgardoc.xml ...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,103,451, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,103,451, According to a Recent SEC Filing
Oct 3, 2025
05:20 PM EDT, 10/03/2025 (MT Newswires) -- Kevin Joseph Fitzgerald, Chief Scientific Officer & Executive Vice President, Head of Research, on October 01, 2025, sold 2,441 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,103,451. Following the Form 4 filing with the SEC, Fitzgerald has control over a total of 25,768 common shares of the company, with 25,231 shares held...
Corcept Therapeutics Insider Sold Shares Worth $3,403,253, According to a Recent SEC Filing
Corcept Therapeutics Insider Sold Shares Worth $3,403,253, According to a Recent SEC Filing
Oct 3, 2025
05:29 PM EDT, 10/03/2025 (MT Newswires) -- Joseph K Belanoff, Director, Chief Executive Officer, on October 01, 2025, sold 40,000 shares in Corcept Therapeutics ( CORT ) for $3,403,253. Following the Form 4 filing with the SEC, Belanoff has control over a total of 2,781,370 common shares of the company, with 2,781,370 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1088856/000119312525230467/xslF345X05/ownership.xml ...
Alnylam Pharmaceuticals Insider Sold Shares Worth $2,692,062, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $2,692,062, According to a Recent SEC Filing
Oct 3, 2025
05:23 PM EDT, 10/03/2025 (MT Newswires) -- Pushkal Garg, Executive Vice President, Chief Research and Development Officer, on October 01, 2025, sold 5,959 shares in Alnylam Pharmaceuticals ( ALNY ) for $2,692,062. Following the Form 4 filing with the SEC, Garg has control over a total of 20,902 common shares of the company, with 20,221 shares held directly and 681...
Copyright 2023-2026 - www.financetom.com All Rights Reserved